Võrdle meetodeid
Vaata valitud meetodeid kõrvuti; erinevad read on esile tõstetud.
| Farmakofoorimudelite loomine× | QSAR× | |
|---|---|---|
| Valdkond | Bioinformaatika | Bioinformaatika |
| Perekond | Process / pipeline | Process / pipeline |
| Tekkeaasta≠ | 1977 | 1964 |
| Looja≠ | Peter Gund | Corwin Hansch |
| Tüüp≠ | Pattern-based virtual screening pipeline | Regression-based predictive modeling pipeline |
| Algallikas≠ | Wermuth, C. G., Ganellin, C. R., Lindberg, P., & Mitscher, L. A. (1998). Glossary of terms used in medicinal chemistry. Pure and Applied Chemistry, 70(5), 1129-1143. DOI ↗ | Hansch, C. & Fujita, T. (1964). Rho-sigma-pi analysis. A method for the correlation of biological activity and chemical structure. Journal of the American Chemical Society, 86(8), 1616-1626. DOI ↗ |
| Rööpnimetused | pharmacophore pattern recognition, 3D pharmacophore | QSAR model, quantitative structure-activity relationship |
| Seotud | 3 | 3 |
| Kokkuvõte≠ | Pharmacophore modeling identifies the spatial arrangement of molecular features (hydrogen bond donors, acceptors, aromatic rings) that are essential for biological activity. Introduced by Gund in 1977, this ligand-based method creates a three-dimensional pattern that can screen chemical libraries and design new active compounds without requiring receptor structure. | Quantitative Structure-Activity Relationship (QSAR) modeling predicts biological activity from molecular structure using statistical or machine learning models. Pioneered by Hansch in 1964, QSAR correlates numerical molecular descriptors with measured bioactivity, enabling prediction of activity for untested compounds and rational lead optimization. |
| ScholarGateAndmestik ↗ |
|
|